# 7-Ketocholesterol promotes T cell migration through Ca2+-NFATc1 pathway-mediated F-actin polymerization and proinflammatory cytokine production in oral lichen planus

**Authors:** Qin Jiang, Yu-Xi Tang, Gang Zhou

PMC · DOI: 10.3389/fimmu.2026.1682589 · Frontiers in Immunology · 2026-02-06

## TL;DR

The study finds that 7-ketocholesterol promotes T cell migration in oral lichen planus through a calcium and NFATc1 signaling pathway, contributing to inflammation.

## Contribution

This is the first study to link 7-ketocholesterol to T cell migration in oral lichen planus via Ca2+-NFATc1 signaling and F-actin polymerization.

## Key findings

- 7-ketocholesterol accumulates in OLP plasma and upregulates cholesterol regulators in T cells.
- 7-ketocholesterol enhances T cell migration through Ca2+-NFATc1 signaling and F-actin polymerization.
- Blocking the Ca2+-NFATc1 pathway reduces T cell migration and proinflammatory cytokine production.

## Abstract

Oral lichen planus (OLP) is a chronic T-cell-mediated inflammatory disorder of unknown etiology. Accumulating evidence has demonstrated elevated cholesterol levels in OLP, and its oxidation products --oxysterols have been implicated in T cell dysfunction. However, whether the oxysterol is involved in OLP pathogenesis remains to be fully elucidated.

Metabolomics was performed to profile oxysterols in the plasma of OLP patients, followed by functional enrichment analysis. Single-cell RNA sequencing was utilized to characterize gene expression dysregulation in tissue-resident T cells isolated from OLP lesions. Flow cytometry, immunofluorescence, and qRT-PCR were collectively used to quantify Ca2+ concentration, cell apoptosis, protein expression, intracellular signaling, and gene transcription levels. Functional validation was conducted through a co-culture model and Transwell migration assays to assess the cytotoxic and migratory capacity of OLP T cells.

The oxysterol profiles were aberrant in OLP plasma, with marked accumulation of 7-ketocholesterol (7KC). Functional analysis identified significant enrichment of differential metabolites in androstenedione metabolism. 7KC upregulated the expression of cholesterol regulators (SREBP2/LXR) in OLP T cells. Pro-7-ketocholesterogenic gene sets were dysregulated in OLP tissues, with localized T cells exhibiting enriched Ca2+ -NFATc1 signaling and coordinated F-actin polymerization/ITGAL (LFA-1α) upregulation, positively correlating with migration signatures. Peripheral OLP T cells showed elevated Ca2+, nuclear NFATc1, F-actin polymerization, and LFA-1α, all of which, along with ITGAL/IL1B/CCL4/IL6 levels, were further potentiated by 7KC treatment. 7KC was confirmed to enhance migrations of primary OLP T cells and OLP plasma-pretreated Jurkat T cells toward LPS-treated keratinocytes, without affecting keratinocyte apoptosis. Furthermore, CM4620-mediated blockade of Ca2+ -NFATc1 pathway in OLP T cells inhibited 7KC-induced NFATc1 activation, reduced the expressions of F-actin and its modulators ACTB/DIAPH1, and IL1B/CCL4/IL6 gene expressions, with migration suppressions of both primary OLP T cells and OLP plasma-pretreated Jurkat T cells.

7KC could promote T cell migration through Ca2+ -NFATc1 pathway-mediated F-actin polymerization and expression of IL1B/CCL4/IL6 in OLP.

## Linked entities

- **Genes:** SREBF2 (sterol regulatory element binding transcription factor 2) [NCBI Gene 6721], lxr (LexA regulated function) [NCBI Gene 2777459], NFATC1 (nuclear factor of activated T cells 1) [NCBI Gene 4772], ACTB (actin beta) [NCBI Gene 60], DIAPH1 (diaphanous related formin 1) [NCBI Gene 1729], ITGAL (integrin subunit alpha L) [NCBI Gene 3683], IL1B (interleukin 1 beta) [NCBI Gene 3553], CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351], IL6 (interleukin 6) [NCBI Gene 3569]
- **Proteins:** ITGAL (integrin subunit alpha L), NFATC1 (nuclear factor of activated T cells 1), Act5C (Actin 5C), CCL4 (C-C motif chemokine ligand 4), IL6 (interleukin 6), IL1B (interleukin 1 beta)
- **Chemicals:** 7-ketocholesterol (PubChem CID 91474), androstenedione (PubChem CID 6128), CM4620 (PubChem CID 122507647)
- **Diseases:** oral lichen planus (MONDO:0043923)

## Full-text entities

- **Genes:** CYP7A1 (cytochrome P450 family 7 subfamily A member 1) [NCBI Gene 1581] {aka CP7A, CYP7, CYPVII}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, LSS (lanosterol synthase) [NCBI Gene 4047] {aka APMR4, CTRCT44, HYPT14, OSC}, STAT4 (signal transducer and activator of transcription 4) [NCBI Gene 6775] {aka DPMC, SLEB11}, CXCR3 (C-X-C motif chemokine receptor 3) [NCBI Gene 2833] {aka CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, DUOX1 (dual oxidase 1) [NCBI Gene 53905] {aka LNOX1, NOXEF1, THOX1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, ANXA5 (annexin A5) [NCBI Gene 308] {aka ANX5, CPB-I, ENX2, HEL-S-7, PP4, RPRGL3}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, CDC42 (cell division cycle 42) [NCBI Gene 998] {aka CDC42Hs, G25K, TKS}, STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, RHOA (ras homolog family member A) [NCBI Gene 387] {aka ARH12, ARHA, EDFAOB, RHO12, RHOH12}, OXT (oxytocin/neurophysin I prepropeptide) [NCBI Gene 5020] {aka OT, OT-NPI, OXT-NPI}, CCR4 (C-C motif chemokine receptor 4) [NCBI Gene 1233] {aka CC-CKR-4, CD194, CKR4, CMKBR4, ChemR13, HGCN:14099}, HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) [NCBI Gene 3156] {aka LDLCQ3, LGMDR28, MYPLG}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, ALOX12 (arachidonate 12-lipoxygenase, 12S type) [NCBI Gene 239] {aka 12-LOX, 12S-LOX, LOG12}, CD28 (CD28 molecule) [NCBI Gene 940] {aka IMD123, Tp44}, ITGB1 (integrin subunit beta 1) [NCBI Gene 3688] {aka CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA}, MPO (myeloperoxidase) [NCBI Gene 4353], ACTB (actin beta) [NCBI Gene 60] {aka BKRNS, BNS, BRWS1, CSMH, DDS1, PS1TP5BP1}, DIAPH1 (diaphanous related formin 1) [NCBI Gene 1729] {aka DFNA1, DIA1, DRF1, LFHL1, SCBMS, hDIA1}, SREBF2 (sterol regulatory element binding transcription factor 2) [NCBI Gene 6721] {aka SREBP-2, SREBP2, bHLHd2}, ALOX15 (arachidonate 15-lipoxygenase) [NCBI Gene 246] {aka 12-LOX, 15-LOX, 15-LOX-1, LOG15}, CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, SQLE (squalene epoxidase) [NCBI Gene 6713], ITGB2 (integrin subunit beta 2) [NCBI Gene 3689] {aka CD18, LAD, LCAMB, LFA-1, MAC-1, MF17}, ITGAL (integrin subunit alpha L) [NCBI Gene 3683] {aka CD11A, EV6, HNA-5, LFA-1, LFA1A}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta) [NCBI Gene 3551] {aka IKK-2, IKK-beta, IKK2, IKKB, IMD15, IMD15A}, NFATC1 (nuclear factor of activated T cells 1) [NCBI Gene 4772] {aka NF-ATC, NF-ATc1.2, NFAT2, NFATc}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}, ITGA4 (integrin subunit alpha 4) [NCBI Gene 3676] {aka CD49D, IA4}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}
- **Diseases:** dyslipidemia (MESH:D050171), Inflammatory (MESH:D007249), T cell dysfunction (MESH:C536780), OLP (MESH:D017676), EOLP lesions (MESH:D009059), autoimmune disease (MESH:D001327), SLE (MESH:D008180), psoriasis (MESH:D011565), atherosclerosis (MESH:D050197), OLP lesion (MESH:D008010), RA (MESH:D001172), cytotoxic (MESH:D064420), endocrine-immune disorder (MESH:D004700), T (MESH:D001260), IBD (MESH:D015212), OPMD (MESH:C537245), MS (MESH:D009103)
- **Chemicals:** PI (MESH:D010716), Ficoll (MESH:D005362), 7-Ketocholesterol (MESH:C003001), methanol (MESH:D000432), Triton X-100 (MESH:D017830), Aldosterone (MESH:D000450), acetonitrile (MESH:C032159), CM4620 (MESH:C000721808), FITC (MESH:D016650), nitrogen (MESH:D009584), androstenedione (MESH:D000735), EDTA (MESH:D004492), testosterone (MESH:D013739), estrone (MESH:D004970), water (MESH:D014867), CCK-8 (MESH:D012844), cholesterol (MESH:D002784), CE (MESH:D002563), isopropanol (MESH:D019840), Acetic acid (MESH:D019342), Amphetamine (MESH:D000661), Oxysterols (MESH:D000072376), FSC-A (-), Alexa Fluor  488 (MESH:C000711379), paraformaldehyde (MESH:C003043), Lipid (MESH:D008055), LPS (MESH:D008070), sterol (MESH:D013261), Hypaque (MESH:D003973), Fluo-3 (MESH:C059715), Steroids (MESH:D013256), SYBR Green (MESH:C098022), CO2 (MESH:D002245), DAPI (MESH:C007293), DMSO (MESH:D004121), formaldehyde (MESH:D005557), ROS (MESH:D017382), Calcium (MESH:D002118), Heparin (MESH:D006493), J (MESH:C000608249)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** C2201S
- **Cell lines:** OLP T — Homo sapiens (Human), Buccal mucosa squamous cell carcinoma, Cancer cell line (CVCL_D859), CCK8 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_2873), T — Homo sapiens (Human), Esophageal squamous cell carcinoma, Cancer cell line (CVCL_3174), Jurkat T — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0065), HOK — Hexagrammos otakii (Fat greenling), Spontaneously immortalized cell line (CVCL_YE19), 7KC — Cricetulus griseus (Chinese hamster), Spontaneously immortalized cell line (CVCL_H340)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12946749/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12946749/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12946749/full.md

---
Source: https://tomesphere.com/paper/PMC12946749